Politics

Fate of New York’s PTSD Bill Rests With Cuomo

Published on June 20, 2017 · Last updated July 28, 2020

A bipartisan proposal that would add post-traumatic stress disorder (PTSD) as a qualifying condition for New York’s medical marijuana program has received final approval from state lawmakers. It now heads to the desk of Gov. Andrew Cuomo for final approval.

The Senate approved S 5629 on a 50–13 vote on Tuesday. The Assembly version of the bill, A 7006, passed with overwhelming support (131­–8) in May.

Veterans advocates, who pushed hard for the  addition, said the move would be a boon to the health and well being of those who served their country and would otherwise have to move out of the state to obtain cannabis legally.

“Military veterans, first responders, and victims who have survived assault all deserve society’s respect and the best available treatments; they should not have to abandon their homes and move to another state in order to seek access to medical marijuana,” Michael Krawitz, executive director of Veterans for Medical Cannabis Access, said in a statement. “This is compassionate and commonsense legislation that is widely supported by the public as well as lawmakers from both sides of the aisle.”

Kate Bell, legislative counsel for the Marijuana Policy Project, added the group hopes Cuomo wastes no time in signing the bill.

“State lawmakers are standing up for thousands of New Yorkers who are suffering from PTSD and might benefit from medical marijuana,” she said. “We hope Gov. Cuomo will do the same and sign this important legislation. With a single swipe of his pen, he can help countless people find relief.”

The bipartisan bill was introduced by Sen. Diane Savino (D-Staten Island) and seven co-sponsors, including Sen. Martin Golden (R-Brooklyn), who previously opposed medical marijuana legislation. The Assembly version was introduced by Assembly Health Committee Chair Richard N. Gottfried (D-Manhattan) with a bipartisan coalition of more than three dozen co-sponsors.

Out of the 29 states with medicinal marijuana programs, 26 of them allow patients with PTSD to qualify for medical marijuana. Both Colorado and Vermont recently added PTSD to their respective lists, and patients in New Hampshire are waiting for the governor’s signature on a bill recently passed by the Legislature.

“In the past year, 11 more states have approved allowing trauma survivors to use cannabis for PTSD. Now only three medical cannabis states exclude PTSD patients,” Bell of MPP said. “Senate Majority Leader John Flanagan and his colleagues should be commended for addressing the needs of New York residents who are dealing with this terrible condition, including our veterans. By signing this legislation, Gov. Cuomo can ensure New Yorkers don’t get left behind.”

Shop highly rated stores near you

Showing you stores near
See all stores
Gage Peake
Gage Peake
Gage Peake is a former staff writer for Leafly, where he specialized in data journalism, sports, and breaking news coverage. He's a graduate of the University of Nebraska-Lincoln's College of Journalism and Mass Communications.
View Gage Peake's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




The material provided on Leafly is intended for educational and informational purposes only. Leafly is not engaged in rendering medical service or advice and the information provided is not a substitute for a professional medical opinion. If you have a medical problem, please contact a qualified health professional.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.